November 16, 2022
Companies in the drug, biologic and medical device spaces may encounter compliance challenges, some of which can lead to government enforcement actions and potential civil, and even criminal, liability. With a constantly evolving regulatory landscape to navigate, how can you address risks while achieving your business objectives? Join Foley Hoag for a multi-part webinar series exploring crisis scenarios facing FDA-regulated companies, with roundtable discussions on actions your company can take to navigate these challenging issues.